Moore Courtenay K, Karikehalli Shridevi, Nazeer Tipu, Fisher Hugh A G, Kaufman Ronald P, Mian Badar M
Division of Urology, Albany Medical College and Stratton Veterans Administration Medical Center, Albany, NY 12208, USA.
J Urol. 2005 Jan;173(1):70-2. doi: 10.1097/01.ju.0000148260.69779.c5.
High grade prostatic intraepithelial neoplasia (HGPIN) and atypical small acinar proliferation (ASAP) in the sextant biopsy had been associated with a high risk of prostate cancer. We determined whether the extended biopsy schemes used in the contemporary era have altered the prognostic value of these lesions at repeat biopsies.
From 1998 to 2003, 105 of 1,188 men had at least 1 repeat extended biopsy due to the presence of HGPIN (33 men) or ASAP (72 men) in a previous extended biopsy. Median biopsy interval for HGPIN and ASAP was 15 and 10 weeks (p <0.05), respectively. Differences in cancer detection rates were analyzed using the Pearson chi-square test.
In the HGPIN group only 1 of 22 (4.5%) men had cancer on 1st repeat biopsy and 0 of 11 men had cancer on 2nd repeat biopsy. In men with ASAP 19 of 53 (36%, p <0.005) had cancer on 1st repeat biopsy, and 3 of 19 (16%) had cancer on 2nd repeat biopsy. Cancer was confined to a single core in 16 of 22 (73%) men. Median Gleason score was 6. Patient age, digital rectal examination status, prostate specific antigen, free prostate specific antigen, number of cores and biopsy interval were not independent predictors of cancer in men with ASAP.
HGPIN found in the contemporary extended biopsy does not warrant repeat biopsy. ASAP continues to be associated with a high risk of cancer and requires at least 1 repeat biopsy using the extended biopsy scheme.
六分区活检中的高级别前列腺上皮内瘤变(HGPIN)和非典型小腺泡增生(ASAP)与前列腺癌的高风险相关。我们确定了当代使用的扩展活检方案是否改变了这些病变在重复活检时的预后价值。
1998年至2003年,1188名男性中有105名因先前扩展活检中存在HGPIN(33名男性)或ASAP(72名男性)而至少进行了1次重复扩展活检。HGPIN和ASAP的中位活检间隔分别为15周和10周(p<0.05)。使用Pearson卡方检验分析癌症检出率的差异。
在HGPIN组中,22名男性中有1名(4.5%)在首次重复活检时发现癌症,11名男性中有0名在第二次重复活检时发现癌症。在ASAP男性中,53名中有19名(36%,p<0.005)在首次重复活检时发现癌症,19名中有3名(16%)在第二次重复活检时发现癌症。22名男性中有16名(73%)的癌症局限于单个活检组织条。中位Gleason评分为6分。患者年龄、直肠指检情况、前列腺特异性抗原、游离前列腺特异性抗原、活检组织条数和活检间隔不是ASAP男性癌症的独立预测因素。
当代扩展活检中发现的HGPIN无需重复活检。ASAP仍然与高癌症风险相关,需要至少使用扩展活检方案进行1次重复活检。